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Background-—The precise mechanisms causing cardiac troponin (cTn) increase after exercise remain to be determined. The aim of
this study was to investigate the impact of heart rate (HR) on exercise-induced cTn increase by using sports watch data from a
large bicycle competition.
Methods and Results-—Participants were recruited from NEEDED (North Sea Race Endurance Exercise Study). All completed a 91-
km recreational mountain bike race (North Sea Race). Clinical status, ECG, blood pressure, and blood samples were obtained
24 hours before and 3 and 24 hours after the race. Participants (n=177) were, on average, 44 years old; 31 (18%) were women.
Both cTnI and cTnT increased in all individuals, reaching the highest level (of the 3 time points assessed) at 3 hours after the race
(P<0.001). In multiple regression models, the duration of exercise with an HR >150 beats per minute was a significant predictor of
both cTnI and cTnT, at both 3 and 24 hours after exercise. Neither mean HR nor mean HR in percentage of maximum HR was a
significant predictor of the cTn response at 3 and 24 hours after exercise.
Conclusions-—The duration of elevated HR is an important predictor of physiological exercise-induced cTn elevation.
Clinical Trial Registration-—URL: https://www.clinicaltrials.gov/. Unique identifier: NCT02166216. ( J Am Heart Assoc. 2020;9:
e014408. DOI: 10.1161/JAHA.119.014408.)
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P rolonged strenuous physical exercise leads to elevation incirculating cardiac troponin (cTn) levels in healthy sub-
jects.1 Although increased cTn levels are considered to reflect
myocardial damage, the exercise-induced cTn elevation in
healthy subjects is considered to be a physiological response.2
The cause and implications of the activity-mediated cTn
response remain to be determined.3,4
We recently demonstrated an inverse correlation
between race duration and exercise-induced cTn elevation,
suggesting that the duration of high-intensity exercise is a
significant determinant of the cTn response.5 Heart rate
(HR) is a major marker of exercise intensity.6 A relationship
between HR during exercise and the exercise-induced cTn
elevation may therefore be anticipated. However, studies
reporting on the relationship between HR and cTn levels
have been conflicting: Some studies have found a relation-
ship between HR and cTn levels,7–10 whereas others have
not.11,12 The relationship between HR and the exercise-
induced cTn response therefore remains obscure. Previous
studies have been subject to several potential limitations:
no study included >100 subjects, and most studies only
reported on the relationship between cTn and mean and
maximum HR.9
The aim of the present study was 3-fold: (1) to describe the
relationship between HR and the exercise-induced cTn
elevation in a larger population of healthy recreational
athletes, (2) to explore the additional value of a comprehen-
sive HR feature analysis for the prediction of the exercise-
induced cTn response, and (3) to determine the presence of a
potential HR threshold associated with the exercise-induced
cTn response.
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Methods
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Study Population
Study subjects were recruited among healthy recreational
cyclists participating in NEEDED (North Sea Race Endurance
Exercise Study) 2014 (NCT 02166216). All study subjects
completed the 91-km recreational mountain-bike race, the
North Sea Race (Figure 1), in 2014. Participants in whom
coronary artery disease was revealed by examinations after the
race were excluded from the present analysis. Recruitment,
inclusion and exclusion criteria, and data sampling in the main
NEEDED 2014 have been described previously.5 HR data were
extracted from personal sport watches used by study subjects
during the race (Figure 2). Digital HR data were harmonized,
and HR features were calculated. The various HR features were
compared with cTn levels acquired before and 3 and 24 hours
after the race. All participants signed informed consent before
enrollment into the study. The study was conducted according
to the Declaration of Helsinki and approved by the Regional
Ethics Committee (Regional Etisk komite No. 2013/550).
Sport Watch Data Processing
The sport watch files containing HR and geopositioning data
were downloaded after the race, on site, sent by e-mail, or
uploaded via a web-based solution delivered by Trainingpeaks
(Trainingpeaks.com, CO). Sport watch data files were pro-
cessed and analyzed at the Department of Electrical Engi-
neering and Computer Science, University of Stavanger,
Stavanger, Norway. The HR files did not contain information
on the specific sport watch type. We were therefore not able
to adjust for the different types of sport watch used.
To minimize the potential differences between different
sport watches, we applied stringent measures to harmonize
data and to ensure as high-data quality as possible. We
excluded all files (n=114; Figure 2) with incomplete data sets,
insufficient data sampling frequency, longer periods of
missing data, or HR=0 (as described below).
The following file types were excluded because of missing
combination of HR and/or geopositioning data: GPX, WKO,
Figure 1. Diagram of heart rate (HR), altitude, and distance at the 91-kmNorth Sea Race. HR is outlined in red, and altitude is in gray. The diagram
is a representative presentation of HR from a single study participant, and the horizontal line is the subject’s mean HR during the race (168 bpm).
Distance (in kilometers) is along the x axis. The diagram is exported from the Garmin Connect website (copyright Garmin International, KS, US).
Clinical Perspective
What Is New?
• The duration of elevated heart rate >150 beats per minute
is an independent and important predictor of exercise-
induced troponin elevation.
• There may be a heart rate threshold associated with an
exercise-induced troponin elevation.
What Are the Clinical Implications?
• Sport watches may be used to monitor exercise intensity
and duration in relation to troponin release.
• The clinical role of heart rate threshold values associated
with exercise-induced troponin elevation needs to be
determined.
• Heart rate threshold of exercise-induced troponin release
may potentially represent both training targets and safety
margins of training.
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HRM, LSX, and OPL (n=14). The files included in the initial
evaluation were CSV files (n=212), FIT (n=38), TCX (n=15),
PWX (n=21), and XML (n=4).
These files were given a unique identifier and imported into
MATLAB (Mathworks Inc, MA) for further processing. The files
were harmonized by accurately defining start/stop of activity. All
data were adjusted to a frequency of 1 HR value (beats per
minute [bpm]) per 1 second. To correct for missing data, HR per
second was interpolated from neighboring HR data. Files that did
not allow harmonization of starting/stopping points or contained
insufficient data to allow HR interpolation every second were
excluded. A total of 177 files were included in the final analysis.
HR Features
HR data were downloaded and analyzed for the whole race, and
mean and maximal HR values were calculated. The theoretical
age-adjusted HR was estimated using the formula of Tanaka
et al.13 The intensity/time domain was analyzed by calculating
the duration of time spent above HR thresholds of 140, 150, and
160 bpm for the complete race. Mean HRs and the time/HR
integrals (above each of these HR thresholds) were calculated.
The purpose of the variable time-HR integral, HR >9bpm, was to
allow an interpretation of the troponin response to the combined
effects of the duration and the magnitude of HR elevation above
the specified HR limit. The time-HR integral corresponds to the
area under the HR curve for all HR values exceeding the given
HR threshold. The chosen HR thresholds were based on prior
studies that suggest a stepwise increase in cTn between mean
HR of 140 and 160 bpm.14 In addition, the time spent with an
HR >85%, >90%, and >95% of the maximal achieved HR during
the race was calculated to allow a global assessment of HR
distribution close to maximal effort.
Blood Samples
Blood samples were acquired 24 hours before and at 3 and 24
hours after exercise. The decision to sample blood at 3 hours
93 did not meet for screening 
6 had CV disease
133 did not start the race
10 did not complete the race
5 incomplete sampling
1 STEMI during the race
9 obstrucve CAD detected
2 myocardial bridging
700 no advanced sport watch
1250 parcipants responded to study parcipaon request
1002 parcipants included in the study
291 parcipants with advanced sport watches
177 parcipants included in final analysis
114 excluded due to data quality 
issues 
Figure 2. Flowchart depicting the recruitment of the study participants. CAD indicates coronary artery
disease; CV, cardiovascular; STEMI, ST-segment–elevation myocardial infarction.
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rather than immediately after exercise was based on the
findings from the NEEDED 2013 pilot study that demon-
strated better hydration and cTn levels more close to the
expected physiological postexercise peak when cTn was
sampled at 3 hours after exercise.15 Venous blood samples
were drawn from the antecubital vein. Cardiac TnI (serum)
was analyzed within 24 hours at Stavanger University Hospi-
tal on an Architect i2000SR using the high-sensitive cTnI STAT
assay from Abbott Diagnostics (IL). Frozen samples were
transported on dry ice to Haukeland University Hospital,
Bergen, Norway; and cTnT was analyzed using a high-
sensitivity cTnT assay on Cobas e601 (Roche Diagnostics,
Switzerland) on first-time thawed serum. The cTnI assay has a
lower limit of detection of 1.6 ng/L, and the 99th percentile
of the assay was set at 26 ng/L. The cTnT assay had a limit of
blank of 3 ng/L and a 99th percentile of 14 ng/L.16
Statistical Analysis
Continuous and fairly symmetrically distributed variables are
reported as meanSD, whereas continuous variables with
markedly skewed distributions are reported as median and
interquartile range, reporting the 25th and 75th percentiles.
The Shapiro-Wilk test was used to test for normality. Mann-
Whitney U test and Student t test were used to test for
difference between groups. For changes over all 3 time points,
a Friedman test was used for markedly skewed distributions
and a repeated-measures ANOVA was used for normally
distributed variables. For comparison between 2 time points,
Wilcoxon signed rank test was used for variables with
markedly skewed distribution and paired Student t test was
used for normally distributed variables. For bivariate correla-
tions, Spearman’s rank-order correlation was used. Because
of the considerable number of statistical tests performed and
the corresponding increased false-positive rate, a P<0.01 was
regarded as significant. Multiple linear regression was used to
study possible associations between HR variables and cTn
levels. Because of markedly skewed distributions, cTn values
were ln transformed. In the multiple regression models, we
prespecified a fixed set of parameters for a basic model based
on our findings from our main study.5 The following variables
were included in this model: age, sex, body mass index, race
duration, systolic blood pressure (SBP), estimated glomerular
filtration rate, low-density lipoprotein, Framingham Risk
Score, resting HR, and baseline ln cTn. Different HR features
were then added to the model one by one to see the changes
in coefficient of determination (R2). The following variables
were added by this method: mean HR, maximum HR, mean HR
in percentage of estimated maximum HR, time spent with an
HR >140, >150, and >160 bpm, integral of time and HR with
an HR >140, >150, and >160 bpm, integral of time with an
HR >85%, >90%, and >95% of maximum achieved HR, mean
HR >140, >150, and >160 bpm, and percentage of race time
with an HR >140, >150, and >160 bpm. Recent data suggest
that training history influences the exercise-induced cTn
response.17 Therefore, in addition to the basic model
described in the Introduction, we constructed a new extended
basic model that also contained training history expressed as
years of endurance training. The following variables were
included in the “extended basic model”: age, sex, body mass
index, race duration, SBP, estimated glomerular filtration rate,
low-density lipoprotein, Framingham Risk Score, resting HR,
baseline ln-cTn, and years of endurance training. Linear
regression models using backward selection and forward
inclusion showed similar effects on both the level of
prediction and the level of significance. For all statistical
analyses, the statistical software programs SPSS, version 24,
and R18 were used.
Results
A total of 177 subjects, 448 years of age, 31 (18%) women,
were included in this analysis (Figure 2). Baseline values for
the included subjects are outlined in Table 1. There was no
former history of diabetes mellitus, hypertension, or heart
disease among study participants. Mean race duration was
3:23 hours for men and 4:00 hours for women (P<0.001).
Maximal and mean HR, as well as total time spent above the
HR thresholds, are shown in Table 2.
cTn and Clinical Variables
Median cTnI at baseline was 1.9 (1.6–3.3) ng/L, increased to
60.0 (36.0–99.3) ng/L at 3 hours (P<0.001) and declined at
24 hours to 10.9 (6.1–22.4) ng/L (P<0.001). A similar profile
was found for cTnT: baseline, <3.0 (<3.0–3.8) ng/L; 3 hours,
38.3 (25.6–55.2) ng/L (P<0.001); and 24 hours, 11.0 (7.2–
17.4) ng/L (P<0.001) (Figure 3). HR at baseline was
5910 bpm. At 3 hours after the race, mean resting HR
increased to 7810 bpm (P<0.001). Both SBP and diastolic
blood pressure were significantly (P<0.001) decreased
3 hours after the race, compared with baseline: SBP, 138
(126–148) mm Hg (baseline) versus 129 (120–172) mm Hg
(3 hours); and diastolic blood pressure, 80 (74–86) mm Hg
(baseline) versus 74 (69–79) mm Hg (3 hours). Blood pres-
sure was lower at 24 hours compared with baseline: SBP, 130
(120–138) mm Hg; and diastolic blood pressure, 73 (68–79)
mm Hg (P<0.001). There was no change in HR at 24 hours
compared with baseline. SBP at baseline was correlated with
cTnI and cTnT levels at 24 hours after the race, but not with
the peak cTn levels 3 hours after the race. There was no
major change in body weight from baseline to 3 and 24 hours
after exercise (Table 1).
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Exercise-Induced Troponin Response and HR
Variables During the Race
Bivariate correlations with cTn and HR variables are
outlined in Table 3. At 3 hours after the race, only time
spent with HR >150 bpm correlated significantly to both
the cTnI (r=0.18; P=0.017) and cTnT (r=0.16; P=0.034)
responses. The same relationship could be found with the
integral of race-time with HR >150 bpm and the percentage
of race-time with an HR >150 bpm. No significant associ-
ation was found to time spent in HR zones defined as the
percentage of maximum HR. The number of episodes with
HR >150 bpm did not correlate with cTn levels at any time
point.
Multiple Regression Models
The basic model reached approximately the same R2 in this
subgroup analysis as in the main study5 (3-hour cTnI R2=0.15
and cTnT R2=0.16; 24-hour cTnI R2=0.36 and cTnT R2=0.28). By
adding HR features, the R2 increased by a maximum of 5
percentage points. Duration of time with an HR of ≥150 bpm
was the only explanatory variable showing significant associ-
ation with both cTnI and cTnT at both 3 and 24 hours. At the
same time, between all the candidate variables, this variable
produced the relatively largest increase in explained variance in
Table 1. Baseline Variables
Variables Values (n=177)
Age, y 43.98.0
Men, n (%) 142 (82)
Weight, kg 82.211.5
BMI, kg/m2 25.62.7
Resting HR at baseline, bpm 5910
SBP at baseline, mm Hg 138 (126 to 148)
DBP at baseline, mm Hg 80 (74 to 86)
Framingham Risk Score 1 (0 to 2)
Training status and competitive experience
Endurance training, y 11.810.6
METs, minimum, min/wk 39482976
No. of endurance competitions in past 5 y 10 (5 to 20)
Biomarkers at baseline
cTnI, ng/L 1.9 (1.6 to 3.3)
cTnT, ng/L <3.0 (<3.0 to 3.8)
Total cholesterol, mmol/L 5.1 (4.5 to 5.7)
LDL, mmol/L 3.10.83
HDL, mmol/L 1.5 (1.3–1.7)
eGFR, mL/min per 1.73 m2 9313
Race data
Race duration (h:min) 3:33 (3:09–3:54)
Change in body weight from
baseline to 3 h, %
0.5 (0.6 to 1.4)
Change in body weight from
baseline to 24 h, %
0.0 (1.0 to 0.81)
Baseline characteristics and race performance in study subjects (n=177). Values
are given as meanSD or median (25th–75th percentile) if markedly skewed
distributions. BMI indicates body mass index; bpm, beats per minute; cTnI, cardiac
troponin I; cTnT, cardiac troponin T; DBP, diastolic blood pressure; eGFR,
estimated glomerular filtration rate; HDL, high-density lipoprotein; HR, heart rate;
LDL, low-density lipoprotein; MET, metabolic equivalent; SBP, systolic blood
pressure.
Table 2. HR Variables During the Race
HR Variables Values
Mean HR, bpm 15811
Maximum HR, bpm 17911
Mean HR of estimated maximum HR, % 896
Maximum HR of estimated maximum HR, % 100 (97–105)
No. of episodes with HR >150 bpm 32 (11–64)
Mean HR >140 bpm, bpm 160 (153–166)
Mean HR >150 bpm, bpm 162 (157–167)
Mean HR >160 bpm, bpm 167 (163–170)
Time-intensity (HR) domain
Race time with HR >140 bpm, min 200 (175–215)
Race time with HR >150 bpm, min 175 (133–203)
Race time with HR >160 bpm, min 97 (36–166)
% Race time with HR >140 bpm, % 98 (91–100)
% Race time with HR >150 bpm, % 88 (63–97)
% Race time with HR >160 bpm, % 52 (16–80)
Time-HR integral HR >140 bpm, HR h 62.5 (43.8–
90.1)
Time-HR integral HR >150 bpm, HR h 30.7 (15.5–
55.5)
Time-HR integral HR >160 bpm, HR h 8.9 (2.1–25.0)
Race time >85% of maximum achieved HR, min 183 (159–211)
Race time >90% of maximum achieved HR, min 159 (88–189)
Race time >95% of maximum achieved HR, min 69 (16–138)
Time-HR integral >85% of achieved
maximum HR, HR h
43.9 (36.8–
52.3)
Time-HR integral >90% of achieved
maximum HR, HR h
19.3
(14.623.7)
Time-HR integral >95% of achieved
maximum HR, HR h
3.7 (2.5–5.4)
HR variables during the race in 177 study subjects. Values are given as meanSD or
median (25th–75th percentile) if markedly skewed distributions. Mean HR >140, >150,
and >160 bpm relates to the mean of HR values exceeding the HR threshold in each
individual. Table 2 reports the distribution of these individual mean HR values between
all study subjects. The distribution of the mean individual HR values was skewed, and
these data are therefore presented as medians (25th–75th percentiles). Bpm indicates
beats per minute; HR, heart rate.
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the regression models of cTn elevation (Table 4). The same
results could be found when using time >150 bpm in percent-
age of total race-duration. The extended basic model (including
years of endurance training as an additional explanatory
variable) increased the R2 in all subgroups compared with the
original basic model derived from the main study. The model
increased the R2 value at 3 hours (cTnI R2=0.25 and cTnT
R2=0.23) and at 24 hours (cTnI R2=0.44 and cTnT R2=0.32).
Also in the extended model, the duration of HR of ≥150 bpm
was the variable with the highest increase in R2 that also
remained significant for both cTnI and cTnT at both time points:
the R2 increased between 3 and 5 percentage points in the
models (Table 5). Full models containing all variables could be
found in the supplemental tables: basic model (Table S1), basic
model with time >150 bpm (Table S2), basic model with
percentage of race duration >150 bpm (Table S3), and
extended basic model with time >150 bpm (Table S4).
Discussion
The present study is the largest study to date to investigate
the relationship between HR and the exercise-induced cTn
response in recreational athletes. The study indicates that the
duration of elevated HR is an important determinant of the
physiological cTn response. Our findings suggest that there
may be a HR threshold defining the lowest exercise intensity
needed to generate an exercise-induced troponin response.
Pure chronotropic measures, such as mean HR and mean HR
in percentage of maximum HR, did not increase the level of
prediction of the cTn response. In contrast, features that
combined HR with duration of exercise improved the predic-
tion models up to 5 percentage points.
During prolonged high-intensity exercise, there is a cTn
elevation in healthy individuals without evidence of myocardial
injury.19 Several mechanisms have been proposed to explain
this response, including increased wall tension and ventricular
strain caused by volume overload, neurohormonal stimulation,
and/or reversible ischemia attributable to increased myocar-
dial energy demands.1,20 In the main NEEDED 2014, we
demonstrated that SBP and race duration were major determi-
nants of the physiological cTn response after exercise.5 The
present study confirms and extends these findings by demon-
strating independent effects of the time-intensity domain on the
prediction models of the exercise-induced cTn response.
A relationship between HR and cTn elevation is expected.
Myocardial perfusion occurs predominantly during diastole.
Increased HR shortens diastole with subsequent decrease in
subendocardial perfusion, potentially inducing ischemia during
exercise. In patients with normal coronary arteries admitted for
supraventricular tachycardia, subjects with elevated troponin T
had significantly higher HR compared to those with normal
levels (191 versus 170 bpm; P=0.008). Furthermore, there was
a significant correlation between maximum HR and the level of
troponin elevation (r=0.64; P=0.001).21 A recent meta-analysis
by Donaldson et al may indicate a potential link between
diastolic function and exercise-induced cTn elevation: In the
Figure 3. Scatter plot of cardiac troponin (cTn) values at all postrace time points. The y axis has been
modified to allow a representative display of both high and low numbers in the same figure. The timing of
blood sampling is represented by the x axis: baseline blood samples were acquired between 24 and
12 hours before the race, whereas blood samples +3 h and +24 h were acquired 3 and 24 hours after the
race, respectively. The dotted lines represent the 99th percentile (high-sensitivity cTnT [hscTnT], 14 ng/L;
and high-sensitivity cTnI [hscTnI], 26 ng/L). The horizontal black lines represent the median value.
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Table 3. Bivariate Correlations
Variables
cTnI + 3 h cTnT + 3 h cTnI + 24 h cTnT +24 h
Rho P Value Rho P Value Rho P Value Rho P Value
Basic variables and race duration
Age 0.10 0.20 0.04 0.62 0.08 0.29 0.04 0.59
Resting HR 0.04 0.57 0.05 0.54 0.09 0.22 0.11 0.14
SBP baseline 0.11 0.14 0.07 0.37 0.22 0.004† 0.17 0.02*
DBP baseline 0.04 0.58 0.04 0.57 0.18 0.02* 0.07 0.37
Resting HR 3 h after the race 0.05 0.49 0.04 0.62 0.09 0.22 0.10 0.21
SBP 3 h after the race 0.15 0.04* 0.09 0.26 0.18 0.02* 0.19 0.01*
DBP 3 h after the race 0.09 0.26 0.02 0.84 0.14 0.07 0.03 0.69
BMI 0.05 0.50 0.05 0.53 0.06 0.44 0.09 0.26
Weight 0.02 0.78 0.02 0.84 0.06 0.46 0.18 0.02*
Waist circumference 0.10 0.18 0.05 0.52 0.02 0.77 0.15 0.04*
METs, min/wk 0.04 0.64 0.05 0.50 0.05 0.53 0.07 0.36
Years of endurance training 0.09 0.24 0.10 0.22 0.05 0.95 0.03 0.67
Race duration 0.13 0.10 0.19 0.01* 0.09 0.22 0.22 0.004†
HR variables during the race
Maximum HR 0.04 0.65 0.01 0.94 0.05 0.52 0.01 0.89
Mean HR 0.13 0.08 0.11 0.14 0.01 0.91 0.03 0.67
Maximum HR in % of
estimated maximum
0.04 0.59 0.01 0.87 0.04 0.63 0.03 0.69
Mean HR in % of estimated
maximum HR
0.10 0.21 0.07 0.34 0.09 0.24 0.06 0.38
No. of HR periods >150 bpm 0.13 0.09 0.11 0.15 0.04 0.61 0.06 0.40
Mean HR >140 bpm 0.16 0.03* 0.13 0.08 0.03 0.75 0.05 0.51
Mean HR >150 bpm 0.13 0.10 0.09 0.23 0.0 1.0 0.02 0.75
Mean HR >160 bpm 0.09 0.22 0.05 0.50 0.03 0.72 0.01 0.94
Time-intensity (HR) domain
Race time with HR >140 bpm 0.12 0.12 0.08 0.28 0.04 0.63 0.03 0.66
Race time with HR >150 bpm 0.18 0.02* 0.16 0.03* 0.06 0.45 0.04 0.59
Race time with HR >160 bpm 0.15 0.05 0.11 0.16 0.00 0.99 0.01 0.90
% Race time with HR >140 bpm 0.18 0.02* 0.18 0.02* 0.06 0.43 0.13 0.10
% Race time with HR >150 bpm 0.19 0.01* 0.18 0.02* 0.06 0.44 0.11 0.15
% Race time with HR >160 bpm 0.18 0.02* 0.14 0.06 0.04 0.60 0.06 0.43
Time-HR integral >140 bpm 0.17 0.03* 0.13 0.08 0.02 0.75 0.04 0.65
Time-HR integral >150 bpm 0.16 0.04* 0.13 0.10 0.01 0.86 0.04 0.64
Time-HR integral >160 bpm 0.13 0.08 0.10 0.20 0.0 0.99 0.03 0.73
Race time >85% of achieved
maximum HR
0.07 0.33 0.08 0.29 0.05 0.50 0.05 0.51
Race time >90% of achieved
maximum HR
0.02 0.81 0.06 0.44 0.00 1.00 0.02 0.76
Race time >95% of achieved
maximum HR
0.01 0.94 0.02 0.78 0.06 0.45 0.02 0.79
Continued
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meta-analysis, exercise HR was the strongest predictor of
increased cTn levels (R2=0.31).22 More important, the analysis
found diastolic function to be influenced by exercise HR and cTn
release, implying that high-intensity exercise elicits cTn release
and reduces left ventricular diastolic function. One may
therefore anticipate the exercise-induced cTn elevation to be
related to increased HR.23 However, as demonstrated by the
present study, it is the combination of duration and HR, and not
solely HR, that relates to the exercise-induced cTn elevation.
Hence, to generate a cTn release, HR elevation must persist for
a certain period. These findings are in line with the study by Lara
et al demonstrating increasing cTnT levels in running compe-
titions of increasing duration.24 Our findings suggest that there
may be an HR threshold required to generate an exercise-
Table 3. Continued
Variables
cTnI + 3 h cTnT + 3 h cTnI + 24 h cTnT +24 h
Rho P Value Rho P Value Rho P Value Rho P Value
Time-HR integral >85% of
achieved maximum HR
0.18 0.02* 0.14 0.06 0.08 0.30 0.03 0.71
Time-HR integral >90% of achieved
maximum HR
0.22 0.004† 0.19 0.01* 0.11 0.13 0.07 0.35
Time-HR integral >95% of achieved
maximum HR
0.19 0.01* 0.16 0.03* 0.11 0.13 0.07 0.36
Bivariate correlations (P values based on Spearman’s rank test) between troponin (cTnI and cTnT) response and baseline and HR variables in blood samples acquired 3 and 24 hours after
the race. BMI indicates body mass index; cTnI, cardiac troponin I; cTnT, cardiac troponin T; DBP, diastolic blood pressure; HR, heart rate; MET, metabolic equivalent; SBP, systolic blood
pressure.
*P<0.05, †P<0.01.
Table 4. Changes After Adding HR Variables to the Basic Multiple Regression Model
Dependent Variables
Ln cTnI 3 h Ln cTnT 3 h Ln cTnI 24 h Ln cTnT 24 h
R2 B P Value R2 B P Value R2 B P Value R2 B P Value
Basic model 0.19 . . . . . . 0.17 . . . . . . 0.37 . . . . . . 0.26 . . . . . .
Mean HR 0.20 0.01 0.18 0.17 0.01 0.29 0.38 0.01 0.48 0.26 0.01 0.22
Mean HR % of estimated maximum HR 0.20 1.88 0.18 0.17 1.08 0.29 0.38 0.93 0.49 0.26 1.08 0.24
Mean HR >140 bpm 0.20 0.02 0.09 0.18 0.01 0.13 0.38 0.01 0.20 0.28 0.01 0.09
Mean HR >150 bpm 0.19 0.01 0.34 0.17 0.01 0.35 0.38 0.01 0.46 0.27 0.01 0.19
Mean HR >160 bpm 0.19 0.00 0.78 0.17 0.01 0.64 0.37 0.01 0.77 0.27 0.01 0.26
Race time with HR >140 bpm 0.23 0.36 0.003 0.21 0.26 0.003 0.39 0.26 0.03 0.29 0.20 0.01
Race time with HR >150 bpm 0.24 0.25 0.001 0.21 0.16 0.002 0.40 0.19 0.009 0.29 0.13 0.01
Race time with HR >160 bpm 0.21 0.12 0.06 0.18 0.07 0.12 0.38 0.07 0.25 0.27 0.06 0.14
% Race time >140 bpm 0.23 1.41 0.004 0.21 1.03 0.003 0.39 1.05 0.02 0.29 0.83 0.009
% Race time >150 bpm 0.24 0.97 0.001 0.21 0.63 0.003 0.40 0.77 0.006 0.30 0.52 0.007
% Race time >160 bpm 0.20 0.43 0.07 0.18 0.26 0.13 0.38 0.29 0.20 0.27 0.25 0.11
Integral of time and HR >140 bpm 0.21 0.005 0.03 0.19 0.00 0.05 0.38 0.00 0.14 0.28 0.00 0.05
Integral of time and HR >150 bpm 0.20 0.01 0.11 0.18 0.00 0.15 0.38 0.00 0.33 0.27 0.00 0.13
Integral of time and HR >160 bpm 0.19 0.00 0.49 0.17 0.00 0.51 0.37 0.00 0.81 0.27 0.00 0.34
Time-HR integral >85% of achieved maximum HR 0.24 0.02 0.001 0.20 0.01 0.02 0.40 0.02 0.006 0.28 0.006 0.10
Time-HR integral >90% of achieved maximum HR 0.24 0.03 0.001 0.20 0.02 0.02 0.41 0.03 0.003 0.28 0.01 0.08
Time-HR integral >95% of achieved maximum HR 0.22 0.09 0.008 0.19 0.05 0.06 0.41 0.09 0.004 0.27 0.04 0.10
This table shows the effects of adding a single extra HR variable to the basic multiple model derived from the main NEEDED (North Sea Race Endurance Exercise Study) 2014. Variables
included in the basic multiple linear regression model were as follows: baseline ln cTnI/cTnT, body mass index, age, sex, race duration, resting HR at baseline, systolic blood pressure at
baseline, low-density lipoprotein cholesterol, estimated glomerular filtration rate, and Framingham Risk Score. Individual HR variables were added to the basic model to assess the impact
of these variables on the R2 and the association with cardiac troponin. The strongest models that were significant at all time points for both cTnT and cTnI were race time with HR
>150 bpm and percentage of race time with an HR >150 bpm (outlined in bold letters). The full basic model is presented in Table S1. cTnI indicates cardiac troponin I; cTnT, cardiac
troponin T; HR, heart rate; R2, coefficient of determination.
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induced cTn response. This is in line with the small (n=10)
mechanistic study by Stewart et al14 that found a difference in
mean HR between subjects with a high (HR, 1603 bpm)
compared with a low (HR, 1452 bpm) cTnI response. In the
study by Stewart et al,14 the exercise protocols were repeated
in the same subjects comparing the same total amount of work,
but with increased intensity (and shortened duration). There
was a highly significant increase in cTnI levels after the high-
intensity compared with the medium-intensity protocol, sug-
gesting that there may be an exercise intensity threshold for
inducing an accentuated cTnI response. Only 10 study subjects
were examined; the possibility to assess interindividual varia-
tions in HR thresholds was therefore limited. The present study
was not able to precisely define the HR threshold associated
with an exacerbated exercise-induced cTn response. Our data
suggest that it may be between 140 and 150 bpm. Future
studies need to address these issues further.
Thedevelopment ofmyocardial stressandmyocardial injury is
reflected by several factors influencing myocardial work
and myocardial energetics. Weil et al20 used infusion of
phenylepinephrine in pigs to induce an increased HR and SBP
with a subsequent increase in cTnI. The cTn elevation occurred
without evidence of myocardial injury.20 These findings suggest
that neurohormonal activation during strenuous exercisemay be
an important determinant of the physiological cTn release. In this
context, HR may be a consequence rather than a determinant of
factors causing a cTn release. Fourth, in line with the main study,
the present analysis found an association between the exercise-
induced cTn elevation andSBP. Fromother studies, we know that
resting SBP is significantly correlated to SBP in exercise25 (Knut
Gjesdal, personal communication [Date of communication: May
27, 2019]). Although we were unable to measure SBP during the
race, these findings may suggest that the exercise-induced cTn
response is exacerbated in subjects likely to have increased
cardiac work during exercise.
Limitations
Our study is a prespecified subgroup analysis of the NEEDED
2014 cohort of presumably healthy recreational athletes with
Table 5. Changes After Adding HR Variables to the Extended Basic Model
Dependent Variables
Ln cTnI 3 h Ln cTnT 3 h Ln cTnI 24 h Ln cTnT 24 h
R2 B P Value R2 B P Value R2 B P Value R2 B P Value
Extended basic model 0.25 . . . . . . 0.23 . . . . . . 0.44 . . . . . . 0.32 . . . . . .
Mean HR 0.26 0.01 0.28 0.23 0.01 0.43 0.44 0.01 0.55 0.33 0.01 0.37
Mean HR % of estimated
maximum HR
0.26 1.61 0.28 0.23 0.86 0.42 0.44 0.81 0.56 0.33 0.81 0.39
Mean HR >140 bpm 0.26 0.02 0.13 0.24 0.01 0.19 0.45 0.01 0.17 0.34 0.01 0.13
Mean HR >150 bpm 0.25 0.01 0.40 0.23 0.01 0.40 0.44 0.01 0.39 0.33 0.01 0.21
Mean HR >160 bpm 0.25 0.004 0.78 0.23 0.01 0.60 0.44 0.01 0.63 0.33 0.01 0.22
Race time with HR >140 bpm 0.28 0.35 0.01 0.25 0.23 0.03 0.46 0.27 0.04 0.34 0.18 0.05
Race time with HR >150 bpm 0.30 0.25 0.003 0.26 0.15 0.01 0.47 0.20 0.01 0.35 0.11 0.04
Race time with HR >160 bpm 0.26 0.10 0.15 0.23 0.05 0.27 0.45 0.07 0.28 0.33 0.05 0.30
% Race time with HR >140 bpm 0.28 1.23 0.02 0.25 0.83 0.03 0.45 0.97 0.06 0.34 0.66 0.06
% Race time with HR >150 bpm 0.29 0.90 0.004 0.26 0.55 0.02 0.47 0.75 0.01 0.34 0.42 0.04
% Race time with HR >160 bpm 0.26 0.35 0.17 0.23 0.18 0.31 0.45 0.27 0.25 0.33 0.17 0.28
Integral of time and HR >140 bpm 0.27 0.005 0.06 0.24 0.003 0.11 0.45 0.004 0.11 0.34 0.003 0.09
Integral of time and HR >150 bpm 0.26 0.004 0.18 0.23 0.003 0.25 0.45 0.003 0.26 0.33 0.003 0.18
Integral of time and HR >160 bpm 0.26 0.003 0.57 0.23 0.002 0.59 0.44 0.002 0.63 0.33 0.003 0.32
Time-HR integral >85% of
achieved maximum HR
0.29 0.02 0.008 0.24 0.01 0.11 0.46 0.01 0.02 0.33 0.003 0.44
Time-HR integral >90% of
achieved maximum HR
0.29 0.03 0.008 0.24 0.01 0.09 0.47 0.02 0.01 0.33 0.01 0.34
Time-HR integral >95% of
achieved maximum HR
0.28 0.08 0.02 0.24 0.04 0.11 0.46 0.08 0.02 0.33 0.02 0.28
This table shows the effects of adding a single extra HR variable to the extended basic model. Variables included in the “extended basic model” are as follows: age, sex, body mass index,
race duration, systolic blood pressure, low-density lipoprotein cholesterol, estimated glomerular filtration rate, Framingham Risk Score, resting HR, baseline ln cTnI/cTnT, and years of
endurance training. The model reaching the highest R2 and keeping significance was race time with an HR >150 bpm (outlined in bold letters). cTnI indicates cardiac troponin I; cTnT,
cardiac troponin T; HR, heart rate; R2, coefficient of determination.
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self-owned advanced sport watches. Our analyses are based on
recordings from several different sport watch producers that
used different data acquisition and storage algorithms. We had
to remove data from 114 subjects because of insufficient data
quality. The present analysis used conventional methods to
harmonize data between the different sport watches, and
extrapolatedmissing data only in files with sufficiently high data
density. However, despite challenges related to data acquisition
and analysis, our findings are consistent, suggesting that simple
chronotropic parameters (mean and maximum HR) are not
related to the exercise-induced cTn elevation if they are not
linked with the duration of exercise. Our findings underscore
that the duration of intensity is more important than short
episodes of high HR. Sampling time of 1 HR value (bpm) per 1
second should therefore be sufficient. Beat-to-beat data were
not available in the current analysis, and amore comprehensive
assessment of HR variability was not possible. We therefore
cannot exclude a relationship between HR variability and the
exercise-induced cTn response. Because there is a link between
HR variability and neurohormonal activation, exploration of
beat-to-beat measurements and the exercise-induced cTn
response is warranted in future studies.
The present study did not assess individual maximal
oxygen uptake or anaerobic threshold. It is therefore not
possible to determine the relationship between cTn levels and
HR at these biological hallmarks.
Conclusions
The present study shows that the duration of elevated HR
is an independent predictor of exercise-induced cTn eleva-
tion. The present study does not allow the determination of
the minimum duration of exercise required to cause an
exacerbated exercise-induced cTn release, and it does not
allow the determination of a potential threshold of HR.
Future studies should aim to identify both the duration and
the HR level associated with an exercise-induced cTn
elevation.
Both the present and earlier studies have used HR as a
surrogate marker of intensity.26 No direct measurement of
cardiac or total work was performed. Development of new
activity trackers and power meters allows more comprehen-
sive measurements of both total work and cardiac work.
Future studies should combine these methods to further
increase our understanding of the underlying mechanisms of
the exercise-induced cTn response.
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Table S1. Basic model. 
Linear Multiple regression calculated by using ENTER method. Full model showing all variables of the 
Basic model without adding heart rate variables. Abbreviations: Cardiac Troponin I (cTnI), cardiac 
Troponin T (cTnT), Body Mass Index (BMI), estimated glomerular filtration rate (eGFR), Low-Density 
Lipoprotein (LDL). 





Ln cTnI (R2=0.19) B Std Error Beta T Sig 
Ln cTnI Baseline 0.25 0.09 0.22 2.94 0.00 
BMI  0.01 0.03 0.02 0.29 0.78 
Age -0.03 0.01 -0.23 -1.77 0.08 
Sex -0.73 0.21 -0.31 -3.43 0.00 
Race duration -0.42 0.14 -0.27 -3.06 0.00 
Resting heart rate 0.00 0.01 0.01 0.13 0.89 
Systolic blood pressure baseline 0.01 0.00 0.13 1.62 0.11 
eGFR 0.01 0.01 0.15 1.86 0.06 
LDL-cholesterol 0.03 0.09 0.03 0.36 0.72 
Framingham Risk Score 0.07 0.04 0.22 1.75 0.08 
Ln cTnT (R2=0.17) 
Ln cTnT Baseline 0.45 0.13 0.26 3.42 0.00 
BMI  -0.01 0.02 -0.04 -0.47 0.64 
Age -0.02 0.01 -0.23 -1.77 0.08 
Sex -0.40 0.15 -0.23 -2.57 0.01 
Race duration -0.34 0.10 -0.30 -3.42 0.00 
Resting heart rate 0.00 0.01 0.01 0.12 0.90 
Systolic blood pressure baseline 0.01 0.00 0.15 1.94 0.05 
eGFR 0.00 0.00 0.06 0.78 0.44 
LDL-cholesterol 0.03 0.06 0.04 0.48 0.63 
Framingham Risk Score 0.05 0.03 0.21 1.60 0.11 
24 hours following race 
Ln cTnI (R2=0.37) B Std Error Beta T Sig 
Ln cTnI Baseline 0.65 0.08 0.52 7.93 0.00 
BMI  0.02 0.03 0.05 0.64 0.52 
Age -0.01 0.01 -0.09 -0.74 0.46 
Sex -0.56 0.20 -0.21 -2.73 0.01 
Race duration -0.27 0.13 -0.16 -2.08 0.04 
Resting heart rate 0.00 0.01 0.01 0.20 0.84 
Systolic blood pressure baseline 0.01 0.00 0.16 2.37 0.02 
eGFR 0.01 0.01 0.11 1.50 0.14 
LDL-cholesterol 0.09 0.08 0.08 1.12 0.26 
Framingham Risk Score 0.07 0.04 0.19 1.69 0.09 
Ln cTnT (R2=0.26) 
Ln cTnT Baseline 0.66 0.12 0.40 5.55 0.00 
BMI  0.00 0.02 0.01 0.12 0.90 
Age -0.02 0.01 -0.20 -1.61 0.11 
Sex -0.11 0.14 -0.07 -0.78 0.44 
Race duration -0.24 0.09 -0.23 -2.73 0.01 
Resting heart rate 0.00 0.00 -0.02 -0.25 0.80 
Systolic blood pressure baseline 0.01 0.00 0.19 2.55 0.01 
eGFR 0.00 0.00 0.04 0.52 0.60 
LDL-cholesterol 0.06 0.05 0.08 1.03 0.31 
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Table S2. Time > 150 bpm. 
Full model, multiple regression ENTER method, containing the heart rate variable that reached the 
highest level of significance and prediction values at all time-points. Abbreviations: Cardiac Troponin I 
(cTnI), cardiac Troponin T (cTnT), Body Mass Index (BMI), estimated glomerular filtration rate (eGFR), 
Low-Density Lipoprotein (LDL). 
3 hours following race      
Ln cTnI (R2=0.24) B Std Error Beta T Sig 
Ln cTnI Baseline 0.27 0.08 0.24 3.29 0.00 
BMI  0.01 0.03 0.04 0.46 0.64 
Age -0.02 0.01 -0.19 -1.54 0.12 
Sex -0.74 0.21 -0.31 -3.60 0.00 
Race duration -0.44 0.13 -0.28 -3.29 0.00 
Resting heart rate -0.01 0.01 -0.07 -0.83 0.41 
Systolic blood pressure baseline 0.01 0.00 0.14 1.79 0.07 
eGFR 0.01 0.01 0.12 1.57 0.12 
LDL-cholesterol -0.01 0.09 -0.01 -0.12 0.90 
Framingham Risk Score 0.09 0.04 0.27 2.20 0.03 
Time > 150 bpm 0.25 0.07 0.27 3.44 0.00 
Ln cTnT (R2=0.21)     
Ln cTnT Baseline 0.48 0.13 0.28 3.76 0.00 
BMI  -0.01 0.02 -0.03 -0.34 0.73 
Age -0.02 0.01 -0.20 -1.57 0.12 
Sex -0.41 0.15 -0.24 -2.73 0.01 
Race duration -0.35 0.10 -0.31 -3.64 0.00 
Resting heart rate 0.00 0.01 -0.06 -0.77 0.44 
Systolic blood pressure baseline 0.01 0.00 0.17 2.15 0.03 
eGFR 0.00 0.00 0.04 0.51 0.61 
LDL-cholesterol 0.00 0.06 0.01 0.07 0.94 
Framingham Risk Score 0.06 0.03 0.25 1.98 0.05 
Time > 150 bpm 0.16 0.05 0.25 3.08 0.00 
24 hours following race      
Ln cTnI (R2=0.40) B Std Error Beta T Sig 
Ln cTnI Baseline 0.67 0.08 0.53 8.25 0.00 
BMI  0.02 0.03 0.06 0.78 0.43 
Age -0.01 0.01 -0.06 -0.53 0.59 
Sex -0.57 0.20 -0.22 -2.82 0.01 
Race duration -0.29 0.13 -0.17 -2.22 0.03 
Resting heart rate 0.00 0.01 -0.04 -0.54 0.59 
Systolic blood pressure baseline 0.01 0.00 0.17 2.51 0.01 
eGFR 0.01 0.01 0.09 1.26 0.21 
LDL-cholesterol 0.06 0.08 0.05 0.74 0.46 
Framingham Risk Score 0.08 0.04 0.23 2.02 0.04 
Time > 150 bpm 0.19 0.07 0.19 2.66 0.01 
Ln cTnT (R2=0.29)      
Ln cTnT Baseline 0.68 0.12 0.41 5.85 0.00 
BMI  0.00 0.02 0.02 0.24 0.81 
Age -0.01 0.01 -0.18 -1.43 0.15 
Sex -0.12 0.14 -0.07 -0.88 0.38 
Race duration -0.25 0.09 -0.24 -2.90 0.00 
Resting heart rate 0.00 0.00 -0.08 -1.00 0.32 
Systolic blood pressure baseline 0.01 0.00 0.20 2.73 0.01 
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LDL-cholesterol 0.04 0.05 0.05 0.68 0.50 
Framingham Risk Score 0.06 0.03 0.26 2.11 0.04 
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Table S3. Percent of race duration > 150 bpm. 
Full model, multiple regression ENTER method, containing the heart rate variable that reached the 
highest level of significance and prediction values at all time-points. Abbreviations: Cardiac Troponin I 
(cTnI), cardiac Troponin T (cTnT), Body Mass Index (BMI), estimated glomerular filtration rate (eGFR), 
Low-Density Lipoprotein (LDL). 
3 hours following race      
Ln cTnI (R2=0.24) B Std Error Beta T Sig 
Ln cTnI Baseline 0.27 0.08 0.24 3.27 0.00 
BMI  0.01 0.03 0.04 0.48 0.63 
Age -0.02 0.01 -0.20 -1.61 0.11 
Sex -0.73 0.21 -0.31 -3.54 0.00 
Race duration -0.24 0.14 -0.15 -1.71 0.09 
Resting heart rate -0.01 0.01 -0.07 -0.85 0.40 
Systolic blood pressure baseline 0.01 0.00 0.14 1.80 0.07 
eGFR 0.01 0.01 0.12 1.56 0.12 
LDL-cholesterol -0.01 0.09 -0.01 -0.13 0.89 
Framingham Risk Score 0.09 0.04 0.29 2.29 0.02 
Percent of race > 150 bpm 0.96 0.29 0.29 3.38 0.00 
Ln cTnT (R2=0.21)     
Ln cTnT Baseline 0.48 0.13 0.28 3.75 0.00 
BMI  -0.01 0.02 -0.03 -0.32 0.75 
Age -0.02 0.01 -0.21 -1.64 0.10 
Sex -0.40 0.15 -0.24 -2.68 0.01 
Race duration -0.23 0.10 -0.20 -2.17 0.03 
Resting heart rate 0.00 0.01 -0.06 -0.80 0.43 
Systolic blood pressure baseline 0.01 0.00 0.17 2.15 0.03 
eGFR 0.00 0.00 0.04 0.50 0.62 
LDL-cholesterol 0.00 0.06 0.00 0.06 0.96 
Framingham Risk Score 0.06 0.03 0.26 2.07 0.04 
Percent of race > 150 bpm 0.63 0.21 0.26 3.05 0.00 
24 hours following race      
Ln cTnI (R2=0.40) B Std Error Beta T Sig 
Ln cTnI Baseline 0.67 0.08 0.53 8.27 0.00 
BMI  0.02 0.03 0.06 0.81 0.42 
Age -0.01 0.01 -0.07 -0.58 0.56 
Sex -0.56 0.20 -0.21 -2.79 0.01 
Race duration -0.13 0.14 -0.08 -0.96 0.34 
Resting heart rate 0.00 0.01 -0.04 -0.61 0.54 
Systolic blood pressure baseline 0.01 0.00 0.17 2.52 0.01 
eGFR 0.01 0.01 0.09 1.24 0.22 
LDL-cholesterol 0.06 0.08 0.05 0.71 0.48 
Framingham Risk Score 0.08 0.04 0.24 2.12 0.04 
Percent of race > 150 bpm 0.77 0.28 0.21 2.77 0.01 
Ln cTnT (R2=0.30)      
Ln cTnT Baseline 0.68 0.12 0.41 5.87 0.00 
BMI  0.00 0.02 0.02 0.27 0.79 
Age -0.01 0.01 -0.18 -1.48 0.14 
Sex -0.11 0.14 -0.07 -0.84 0.40 
Race duration -0.15 0.09 -0.14 -1.61 0.11 
Resting heart rate -0.01 0.00 -0.08 -1.07 0.29 
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eGFR 0.00 0.00 0.02 0.27 0.79 
LDL-cholesterol 0.03 0.05 0.05 0.64 0.52 
Framingham Risk Score 0.06 0.03 0.27 2.22 0.03 
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Table S4. Extended Basic Model with Time > 150 bpm. 
Full model, multiple regression ENTER method, containing the heart rate variable that reached the 
highest level of significance and prediction values at all time-points. In addition to the variables in 
Basic model, Extended Basic Model contains Years of Endurance training as a separate variable. 
Abbreviations: Cardiac Troponin I (cTnI), cardiac Troponin T (cTnT), Body Mass Index (BMI), estimated 
glomerular filtration rate (eGFR), Low-Density Lipoprotein (LDL). 
3 hours following race      
Ln cTnI (R2=0.30) B Std Error Beta T Sig 
Ln cTnI Baseline 0.28 0.09 0.24 3.23 0.00 
BMI 0.01 0.03 0.04 0.44 0.66 
Age -0.02 0.01 -0.22 -1.68 0.10 
Sex -0.82 0.21 -0.34 -3.83 0.00 
Years of endurance training -0.01 0.01 -0.11 -1.32 0.19 
Race duration -0.51 0.14 -0.32 -3.60 0.00 
Resting heart rate -0.01 0.01 -0.13 -1.60 0.11 
Systolic blood pressure baseline 0.01 0.00 0.17 2.21 0.03 
eGFR 0.01 0.01 0.11 1.42 0.16 
LDL-cholesterol 0.03 0.10 0.02 0.27 0.79 
Framingham Risk score 0.10 0.04 0.31 2.36 0.02 
Time > 150 bpm 0.25 0.08 0.26 3.06 0.00 
Ln cTnT (R2=0.26) B Std Error Beta T Sig 
Ln cTnT Baseline 0.51 0.13 0.30 3.86 0.00 
BMI -0.01 0.02 -0.02 -0.25 0.80 
Age -0.02 0.01 -0.25 -1.87 0.06 
Sex -0.49 0.16 -0.29 -3.14 0.00 
Years of endurance training -0.01 0.01 -0.17 -2.00 0.05 
Race duration -0.39 0.10 -0.34 -3.81 0.00 
Resting heart rate -0.01 0.01 -0.12 -1.45 0.15 
Systolic blood pressure baseline 0.01 0.00 0.20 2.45 0.02 
eGFR 0.00 0.00 0.03 0.32 0.75 
LDL-cholesterol 0.03 0.07 0.03 0.37 0.71 
Framingham Risk score 0.08 0.03 0.32 2.35 0.02 
Time > 150 bpm 0.15 0.06 0.22 2.53 0.01 
24 hours following race      
Ln cTnI (R2=0.47) B Std Error Beta T Sig 
Ln cTnI Baseline 0.68 0.08 0.56 8.46 0.00 
BMI 0.03 0.03 0.07 0.95 0.34 
Age -0.01 0.01 -0.06 -0.53 0.60 
Sex -0.64 0.20 -0.25 -3.18 0.00 
Years of endurance training -0.01 0.01 -0.09 -1.33 0.19 
Race duration -0.37 0.13 -0.21 -2.76 0.01 
Resting heart rate -0.01 0.01 -0.10 -1.42 0.16 
Systolic blood pressure baseline 0.01 0.00 0.19 2.74 0.01 
eGFR 0.01 0.01 0.07 0.98 0.33 
LDL-cholesterol 0.05 0.09 0.04 0.56 0.58 
Framingham Risk score 0.09 0.04 0.25 2.14 0.03 
Time > 150 bpm 0.20 0.08 0.19 2.59 0.01 
Ln cTnT (R2=0.35) B Std Error Beta T Sig 
Ln cTnT Baseline 0.73 0.12 0.45 6.28 0.00 
BMI 0.01 0.02 0.04 0.44 0.66 
Age -0.02 0.01 -0.20 -1.61 0.11 
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Years of endurance training -0.01 0.00 -0.12 -1.51 0.13 
Race duration -0.29 0.09 -0.27 -3.21 0.00 
Resting heart rate -0.01 0.00 -0.14 -1.79 0.08 
Systolic blood pressure baseline 0.01 0.00 0.25 3.28 0.00 
eGFR 0.00 0.00 0.00 0.06 0.95 
LDL-cholesterol 0.04 0.06 0.05 0.65 0.51 
Framingham Risk score 0.06 0.03 0.28 2.15 0.03 
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